
Friday, February 07, 2025 2:31:22 PM
Volume: | - |
Day Range: | |
Bid: | 6.40 |
Ask: | 6.49 |
Last Trade Time: | |
Total Trades: |
Recent MNMD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2025 08:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2025 08:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2025 08:30:07 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/06/2025 12:40:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2025 12:30:12 PM
- MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 • Business Wire • 02/20/2025 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/05/2025 10:28:45 PM
- MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference • Business Wire • 02/04/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2025 12:45:08 PM
- MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder • Business Wire • 01/30/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2024 09:31:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2024 09:31:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2024 09:30:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/26/2024 09:39:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/26/2024 09:30:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/26/2024 09:28:56 PM
- MindMed to Be Added to the Nasdaq Biotechnology Index • Business Wire • 12/19/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2024 12:30:10 PM
- MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) • Business Wire • 12/16/2024 12:00:00 PM
- MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress • Business Wire • 12/11/2024 12:00:00 PM
- MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD) • Business Wire • 12/05/2024 12:00:00 PM
- MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy • Business Wire • 12/03/2024 12:00:00 PM
- MindMed Announces New Employee Inducement Grants • Business Wire • 12/02/2024 12:00:00 PM
- MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer • Business Wire • 11/18/2024 12:00:00 PM
The Crypto Company Expands Leadership Team With Experienced Financial and Blockchain Professionals • CRCW • Mar 13, 2025 9:23 AM
ConnectM Announces $10 Million Share Repurchase Program • CNTM • Mar 13, 2025 9:13 AM
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making • SIGY • Mar 12, 2025 9:41 AM
$PYPD - PolyPid Hits Major Milestone: Completes Trial Enrollment, Poised for Potential Breakthrough in $10 Billion Surgical Infection Market • NRXS • Mar 11, 2025 10:30 AM
UC Asset Acquired $3M Cannabis Property via Non-Cash Deal • UCASU • Mar 11, 2025 9:53 AM
1606 Corp. Signs LOI to Be Acquired by Private Group Seeking to Enter the Public Markets and Utilize AI Technologies for Potential Uplisting • CBDW • Mar 11, 2025 8:30 AM